Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients

NCT02324400 is registered in ClinicalTrials.gov with Nephera Ltd. as lead sponsor.

NCT NCT02324400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients
Lead sponsor
Nephera Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
Not reported
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart decompensation, heart failure, congestive, renal insufficiency